Probiotix Health (AQSE:PBX) Defensive Interval Ratio

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

AQSE:PBX Probiotix Health PLC AQSE:PBX
35 GF Score
Price £0.11
GF Value £0.09
Valuation Modestly Overvalued
! 4 Warning Signs
View Full Analysis

What is Probiotix Health Defensive Interval Ratio?

AQSE:PBX
35GF Score
Probiotix Health PLC AQSE:PBX
Defensive Interval Ratio is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Probiotix Health (AQSE:PBX) Overvalued in 2026?

Based on GuruFocus' analysis, Probiotix Health stock appears to be overvalued. The current stock price of £0.11 is trading 16.7% above its estimated GF Value™ of £0.09. GuruFocus considers Probiotix Health to be Modestly Overvalued.

Key valuation signals for AQSE:PBX:

  • Defensive Interval Ratio:
  • GF Value™: £0.09 vs. price of £0.11 (16.7% above fair value)
  • GF Score™: 35/100 with 4 warning signs

No single metric tells the full story. See the AQSE:PBX stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Probiotix Health Business Description

Address Nostell Business Estate, First Floor Zucchi Suite, Wakefield, GBR, WF4 1AB
Probiotix Health PLC is a life sciences company that develops probiotics to tackle cardiovascular disease and other lifestyle conditions that are affecting growing numbers of people across the world. The company has one class of business, in three geographical areas, being that of identifying and developing microbial strains, compounds and formulations for use in the nutraceutical industry. Its geographical segments include the United Kingdom, the United States, and the Rest of the World. It generates the majority of its revenue from the United States.
35GF Score

Get the complete analysis for AQSE:PBX

Defensive Interval Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

£0.11
Price
£0.09
GF Value